|
 The Karnataka Pharma Retailers & Distributors Organization (KPRDO) has reported a sharp increase in patient enquiries and concerns over the availability of Freestyle Libre sensors, following Abbott’s recent decision to restrict distribution of the popular glucose monitoring device exclusively to online platforms.
Patients who rely on Freestyle Libre sensors for continuous glucose monitoring (CGM), particularly those with Type 1 and insulin-dependent Type 2 diabetes, have been caught off guard by the sudden lack of availability at local pharmacies. This shift in distribution has created confusion and frustration among diabetic patients, many of whom depend on timely access to the sensors for effective glucose management.
“We have noticed that Abbott is not supplying Freestyle Libre sensors to brick-and-mortar pharmacies, while online players are receiving free supplies. This disparity raises concerns about fairness and equal opportunities in the distribution process. KPRDO members are receiving daily calls and walk-in enquiries from distressed patients who are unable to source their sensors locally. This not only disrupts continuity of care but also puts patients at risk of complications due to delayed or missed glucose monitoring,” said C. Jayaram, president, KPRDO, in his communication to Robert B. Ford, Chairman and chief executive officer, Abbott Diabetes Care India.
“Retail pharmacists have expressed concern that the online-only distribution model leaves out a significant portion of the population who may lack internet access, digital literacy, or the ability to navigate online purchasing platforms especially elderly patients and those in rural areas,” he added.
Now KPRDO has urged Abbott to reconsider its distribution strategy and resume supplying Freestyle Libre sensors to licensed pharmacy outlets across Karnataka to ensure equitable access and patient safety.
We are writing to express our concern about the distribution strategy for Freestyle Libre sensors in Karnataka, in spite of communication to Abbott representative, the company failed to address the issue. We have also gathered that the company’s expiry policy is not friendly, added Jayaram.
We kindly request that Abbott should reconsider its distribution strategy to ensure that physical pharmacy outlets have access to Freestyle Libre sensors. This would enable us to continue providing service to our customers and support the growth of Abbott's products in the region, he noted.
By supplying Freestyle Libre sensors to brick-and-mortar pharmacies, Abbott can have stronger relationships with retailers who have been loyal to the brand. It will improve its customer service and ensure that patients have access to sensors and support through local retailers, he said.
Further Jayaram said, “Increased product visibility will promote Freestyle Libre sensors through local retailers will expand access and awareness. We believe that a fair and inclusive distribution strategy would benefit both Abbott and pharmacy stores. In this regard, we look forward to discussing this matter further and finding a solution that works for all parties involved.”
Also, we would finally like to bring to your kind notice that this issue is not attended for last 2 months, if not resolved in near future we have to write to Competition Commission of India for Monopolistic Trade practices, Jayaram warned.
|